The 10th of October marked "World Mental Health Day", also a part of "Mental Health Week" in Australia. The day encourages the public to speak opeanly about mental health education, awareness and advocacy against social stigma. Hashhtags like #light-up-purple and #worldmentalhealthday having been trending on Facebook and Twitter as messages of support and awareness are shared all over the world.
In the latest issue of the journal EMBO Molecular Medicine, esteemed psychologists from the University of Bochum in Germany claim the effects of psychiatric drugs used for treating mental illnesses such as depression, anxiety and ADHD only have short-term effects with negative long-term repercussions.
Experts from the cognitive neuroscience research community have penned an open letter expressing their concern about members of the public applying electric current to the brain with home-use tDCS devices.
Economists put a dollar figure on the cost of mental health annually in Australia, estimating the financial impact is equivalent to 12% of annual economic output, mostly due to increased days of work due to poor health and performance.
Authors Christopher Davey and Andrew Chanen call for alternatives to anti-depressant medication to improve outcomes for patients suffering depression. They highlight in their article that while anti-depressants still have an important role in patient treatment, medication is more effective if given in combination with other therapies. You can read the full article here.
Workplace Editor Anna Patty of the Sydney Morning Herald explains how psychiatrists in Australia are increasingly becoming dissatisfied and find it hard to do their work with the limited resources available in hospitals and the community. The full article can be found here.
In association with the APS Neurofeedback and Psychology Interest Group, neuroCademy hosts first symposium in Sydney, Australia, to present the latest findings on non-pharmaceutical treatments of ADHD & Depression.
Results from the large multicenter randomized iSPOT-D study were published in Clinical Neurophysiology demonstrating that brain activity can assist in predicting antidepressant treatment outcome to commonly used antidepressant drugs